Complications Found in Proposed Prostate Cancer Treatment, Efforts To Hinder A Protein Called IGF-1 Not Entirely Successful, Fred Hutchinson Cancer Research Center Study

ScienceDaily (May 1, 2008) — Therapies under development to treat prostate cancer by inhibiting the ability of insulin-like growth factor (IGF-1) to activate its target receptor could have unexpected results especially if a major tumor suppressor gene -- p53 -- is already compromised, according to new research by investigators at Fred Hutchinson Cancer Research Center.